Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Wilms tumor
Trial Status:  Active
Results 1-25 of 35 for your search:
Start Over
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NICHD
Protocol IDs: PPRU 10762, NCT00491946
Collaborative Wilms Tumour Africa Project
Phase: Phase IV
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: CollabWilmsAfrica, NCT01991652
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000257531, SIOP-WT-2001, SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
Comparative Evaluation of MRI and MDCT for the Detection of Metastic Pulmonary Nodules
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: 1000010635, NCT00751920
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 2013-062, NCI-2013-02001, P30CA022453, NCT01987596
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: BMT 0499 Solid, NCT00179816
Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and over
Sponsor: Other
Protocol IDs: 09-090, NCT01099644
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Phase: Phase I
Type: Treatment
Status: Active
Age: 2 to 21
Sponsor: Other
Protocol IDs: RADIANT, NCI-2012-00588, NCT01625351
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 to 25
Sponsor: NCI
Protocol IDs: 130152, 13-C-0152, NCT01875601
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HIFU3917, NCT02076906
ODSH + ICE Chemotherapy in Pediatric Solid Tumors
Phase: Phase I
Type: Supportive care, Treatment
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: NYMC-165, NCT02164097
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 29
Sponsor: Other
Protocol IDs: IRB00078790, NCT02390843
Gene Expression Profiles to Categorize Wilms Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: AREN03B1, NCI-2009-00415, CDR0000349184, COG-AREN03B1, U10CA098543, NCT00897637
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 21 and under at diagnosis, any age at study entry
Sponsor: NCI, Other
Protocol IDs: ALTE03N1, NCI-2011-03822, COG-ALTE03N1, CDR0000360708, U10CA095861, U10CA180886, NCT00082745
Transplant Patient Registry of Liver, Kidney and/or Pancreas
Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: VCU3127, NCT00238693
Study of Kidney Tumors in Younger Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status: Active
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AREN03B2, NCI-2009-00416, COG-AREN03B2, U10CA180886, U10CA098543, NCT00898365
Collecting and Storing Tissue From Young Patients With Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: ABTR04B1, COG-ABTR04B1, NCI-2009-00326, NCT00898755
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HSC20050218H, NCT00575809
Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: VCZ_TDM_Korea, NCT00673348
Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
Phase: No phase specified
Type: Genetics
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: P80-099, PO1 CA34936-23, NCT00503893
Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: Child
Sponsor: NCI
Protocol IDs: 03-123, NCI CA 83132, NCT00578630
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Phase: No phase specified
Type: Genetics
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000640299, VU-VICC-REACH-0901, VU-VICC-PED-0901, FHCRC-2023, IRB# 090032, VICCREACH0901, NCT00949052
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 16 and under
Sponsor: NCI, Other
Protocol IDs: AREN10B2, NCI-2011-02230, CDR0000672402, U10CA098543, COG-AREN10B2, NCT01118078
Childhood Cancer Survivor Study
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: Under 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: CCSS, U24CA055727, R03CA169150, R01CA134722, R01CA136783, R01CA132899, R01CA187397, R01CA175231, NCT01120353
Start Over